Healthcare & pharma stocks — P/E and P/S valuations

Compare global pharmaceutical, biotech, and healthcare leaders by trailing P/E, latest-quarter P/E, and P/S.

Healthcare Stocks trailing P/E, latest-quarter P/E, trailing P/S, and market cap
tickercompanyP/E · trailingP/E · quarterP/S · trailingmarket cap
LLYEli Lilly & Co45.949.114.7US$1.27tn
JNJJohnson & Johnson40.5775.16.6US$651.11bn
ABBVAbbVie Inc49.130.17.7US$505.89bn
UNHUnitedHealth Group Inc19.218.50.7US$304.51bn
NVONOVO NORDISK CLASS B8.85.53.3US$168.87bn
MRKMerck & Co Inc134.416.34.9US$329.65bn
PFEPfizer Inc36.0-157.42.5US$156.17bn
AZNASTRAZENECA PLC26.127.24.4US$272.33bn

Frequently asked questions

Why do pharma P/E ratios vary so widely?

High-growth drug pipelines (such as obesity and oncology leaders) often trade at higher multiples, while mature patent-cliff portfolios trade at lower P/E ratios.

More stock categories

Sources and methodology

Every stock P/E and P/S ratio is calculated directly from price, share count, and reported company earnings and revenue, normalised to USD. Informational research, not investment advice.

Browse all stocks Read investor guides